Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study Of Gemcitabine And Bendamustine In Patients With Relapsed Or Refractory Hodgkin's Lymphoma

NCT01535924 is registered in ClinicalTrials.gov with Beth Christian as lead sponsor.

NCT NCT01535924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01535924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study Of Gemcitabine And Bendamustine In Patients With Relapsed Or Refractory Hodgkin's Lymphoma
Lead sponsor
Beth Christian
Phase
Phase 1/2
Overall status
Completed
Start date
February 9, 2012
Completion date
February 20, 2019
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult lymphocyte depletion hodgkin lymphoma, adult lymphocyte predominant hodgkin lymphoma, adult mixed cellularity hodgkin lymphoma, adult nodular lymphocyte predominant hodgkin lymphoma, adult nodular sclerosis hodgkin lymphoma, recurrent adult hodgkin lymphoma